Systematic review: Patient‐related, microbial, surgical, and histopathological risk factors for endoscopic post‐operative recurrence in patients with Crohn's disease
Alimentary Pharmacology & Therapeutics
by Michiel T. J. Bak, Karlijn Demers, Nassim Hammoudi, Matthieu Allez, Mark S. Silverberg, Gwenny M. Fuhler, Kaushal Parikh, Marieke J. Pierik, Laurents P. S. Stassen, C. Janneke van der Woude, Michail Doukas, Oddeke van Ruler, Annemarie C. de Vries
2d ago
Risk factors for ePOR in international guidelines are not consistently reported as risk factors in the current literature except for active smoking and a prior bowel resection. To develop evidence-based and personalised strategies, future large prospective studies are warranted for the identification of risk factors for ePOR in patients with CD. In addition, validation studies of promising (bio)markers are required. Summary Background Risk stratification for endoscopic post-operative recurrence (ePOR) in Crohn's disease (CD) is required to identify patients who would benefit most from initia ..read more
Visit website
Letter: Retargeting the lens—From general ChatGPT to specialised medical LLMs
Alimentary Pharmacology & Therapeutics
by Shuo Wang, Shotaro Kinoshita, Hiromi M. Yokoyama
2d ago
Alimentary Pharmacology &Therapeutics, EarlyView ..read more
Visit website
Letter: Shifting focus—From ChatGPT to specialised medical LLMs: Authors' reply
Alimentary Pharmacology & Therapeutics
by Mauro Giuffrè, Simone Kresevic, Kisung You, Johannes Dupont, Jack Huebner, Alyssa Ann Grimshaw, Dennis Legen Shung
2d ago
Alimentary Pharmacology &Therapeutics, EarlyView ..read more
Visit website
Editorial: Retreatment of direct‐acting antiviral failures with the current first‐line regimens for patients with chronic hepatitis C
Alimentary Pharmacology & Therapeutics
by Eiichi Ogawa
3d ago
Alimentary Pharmacology &Therapeutics, EarlyView ..read more
Visit website
Editorial: Surgery to reduce opioid use in Crohn's disease: Does a classic solution address a newer problem?
Alimentary Pharmacology & Therapeutics
by Tarun Chhibba
5d ago
Alimentary Pharmacology &Therapeutics, EarlyView ..read more
Visit website
Editorial: Redefining liver health—Personalised approach to assessment of serum ALT in clinical practice. Authors' reply
Alimentary Pharmacology & Therapeutics
by Eunice X. X. Tan, Daniel Q. Huang, Mindie H. Nguyen
5d ago
Alimentary Pharmacology &Therapeutics, EarlyView ..read more
Visit website
Characterisation of an outbreak of acute liver injury after ingestion of plant‐based food supplement
Alimentary Pharmacology & Therapeutics
by Gina Choi, Jawad Ahmad, Victor Navarro, Swan Thung, Ikhlas Khan, Bharathi Avula, Huiman Barnhart, Andrew Stolz, the Drug‐Induced Liver Injury Network
5d ago
Summary Background In April 2022, French Lentil and Leek Crumble (FLLC), a new frozen food preparation manufactured by Daily Harvest™ (containing Tara flour) was offered as a natural high-protein meal product. Soon thereafter, widespread anecdotal reports of acute gastrointestinal symptoms with liver injury were reported, leading to its voluntary withdrawal in June 2022, after shipment of 28,000 preparations. Aims To summarise the clinical and laboratory features of 17 patients with FLLC associated liver injury from the Drug Induced Liver Injury Network (DILIN). Methods Patients with FLLC-ass ..read more
Visit website
Financial hardship and cost‐related nonadherence to medication in patients with liver disease in the United States
Alimentary Pharmacology & Therapeutics
by Donghee Kim, Richie Manikat, Karn Wijarnpreecha, Aijaz Ahmed
1w ago
About one in five individuals with chronic liver disease (CLD)/cirrhosis experienced an inability to pay their medical bills due to financial hardship or cost-related nonadherence to medication. Over two in five individuals with CLD/cirrhosis reported difficulties in accessing medical care due to the COVID-19 pandemic. Summary Background Economic hardship associated with chronic liver disease (CLD) may delay timely access to healthcare. Aim To estimate the national burden of financial hardship across the spectrum of CLD in the United States (US) during the coronavirus disease 2019 (COVID-19 ..read more
Visit website
Psychiatric disorders in patients with hepatocellular carcinoma: A large US cohort of commercially insured individuals
Alimentary Pharmacology & Therapeutics
by Mausam J. Patel, Alex Jones, Yue Jiang, Prajwal Gowda, Lisa B. VanWagner, Thomas G. Cotter, Karim Seif El Dahan, Jeremy Louissaint, Madhukar Patel, Nicole E. Rich, Amit G. Singal, Sarah R. Lieber
1w ago
In a large cohort of >11,000 patients, 2 of 10 patients with hepatocellular carcinoma (HCC) had a psychiatric diagnosis after diagnosis. Women, higher comorbidity, cirrhosis-related decompensations and type of HCC treatment were associated with incident psychiatric diagnosis after HCC diagnosis. Treatment patterns varied with ~19% of patients stopping psychiatric therapy post-HCC diagnosis. Summary Background/Aims Patients with hepatocellular cancer (HCC) are vulnerable to psychological distress given a new cancer diagnosis superimposed on pre-existing chronic liver disease. We aimed to c ..read more
Visit website
Repeatability of vibration‐controlled transient elastography versus magnetic resonance elastography in patients with cirrhosis: A prospective study
Alimentary Pharmacology & Therapeutics
by Harris Siddiqi, Daniel Q. Huang, Nikita Mittal, Nabil Nourredin, Ricki Bettencourt, Egbert Madamba, Maral Amangurbanova, Christie Hernandez, Claude Sirlin, Meng Yin, Rohit Loomba
1w ago
Magnetic resonance elastography (MRE) and vibration-controlled transient elastography (VCTE) demonstrated increased measurement variability with disease severity. MRE outperformed VCTE in terms of technical repeatability in patients with cirrhosis. These repeatability estimates may improve the qualification of non-invasive tests in clinical practice and research. Summary Background and Aims Magnetic resonance elastography (MRE) and vibration-controlled transient elastography (VCTE) have the potential to assess disease progression; however, repeatability data in people with cirrhosis are lack ..read more
Visit website

Follow Alimentary Pharmacology & Therapeutics on FeedSpot

Continue with Google
Continue with Apple
OR